HOSPITAL UNIVERSITARIO QUIRÓNSALUD MADRID
Departamento
Università de Roma La Sapienza
Roma, ItaliaPublicaciones en colaboración con investigadores/as de Università de Roma La Sapienza (11)
2022
-
Effective Overall Glycaemic Control with Fast-Acting Insulin Aspart Across Patients with Different Baseline Characteristics: A Post Hoc Analysis of the Onset 9 Trial
Diabetes Therapy, Vol. 13, Núm. 4, pp. 761-774
2021
-
Alemtuzumab outcomes by age: Post hoc analysis from the randomized CARE-MS studies over 8 years
Multiple Sclerosis and Related Disorders, Vol. 49
-
SARS-CoV-2 infection in patients with primary Sjögren syndrome: Characterization and outcomes of 51 patients
Rheumatology (United Kingdom), Vol. 60, Núm. 6, pp. 2946-2957
2020
-
Efficacy of teriparatide compared with risedronate on FRAX®-defined major osteoporotic fractures: results of the VERO clinical trial
Osteoporosis International, Vol. 31, Núm. 10, pp. 1935-1942
-
Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum
American Journal of Human Genetics, Vol. 107, Núm. 3, pp. 499-513
-
Psychotropic medications and proton pump inhibitors and the risk of fractures in the teriparatide versus risedronate VERO clinical trial
Bone, Vol. 130
2019
-
Serum 25-hydroxy-vitamin D and the risk of fractures in the teriparatide versus risedronate VERO clinical trial
Archives of Osteoporosis, Vol. 14, Núm. 1
-
Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: Prevalence and clinical relevance in a large international, multi-ethnic cohort of patients
Clinical and Experimental Rheumatology, Vol. 37, pp. S97-S106
-
The Big Data Sjögren consortium: A project for a new data science era
Clinical and Experimental Rheumatology, Vol. 37, pp. S19-S23
2018
-
Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial
Journal of Bone and Mineral Research, Vol. 33, Núm. 5, pp. 783-794
-
How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: Analysis of 10,500 patients (Sjögren Big Data Project)
Clinical and Experimental Rheumatology, Vol. 36, pp. S102-S111